TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Rupro AS
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
5,015
|
7,964
|
5,887 |
| Financial expenses |
50
|
44
|
39 |
| Earnings before taxes |
-475
|
468
|
-41 |
| Total assets |
2,182
|
3,487
|
2,720 |
| Current assets |
1,555
|
2,864
|
1,950 |
| Current liabilities |
1,228
|
1,974
|
1,364 |
| Equity capital |
474
|
889
|
654 |
| - share capital |
133
|
128
|
135 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
21.7%
|
25.5%
|
24.0% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-9.5%
|
5.9%
|
-0.7% |
| Return on assets (ROA) |
-19.5%
|
14.7%
|
-0.1% |
| Current ratio |
126.6%
|
145.1%
|
143.0% |
| Return on equity (ROE) |
-100.2%
|
52.6%
|
-6.3% |
| Change turnover |
-2,443
|
2,386
|
-48 |
| Change turnover % |
-33%
|
43%
|
-1% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.